financetom
Business
financetom
/
Business
/
Viewbix Intends to Acquire Innovative Quantum Computing Technologies Company, Quantum X Labs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Viewbix Intends to Acquire Innovative Quantum Computing Technologies Company, Quantum X Labs
Nov 5, 2025 5:18 AM

Company Signed a Non-Binding Term Sheet for a security exchange between the parties 

Tel Aviv, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Viewbix Inc. ( VBIX ) (“Viewbix” or the “Company”), a global developer of ad-tech innovative technologies, today announced the signing of a non-binding term sheet outlining the proposed terms for the acquisition of Quantum X Labs Ltd. (“Quantum X Labs” and the “Acquisition”).

Under the terms of the term sheet, upon the closing of the Acquisition, Viewbix ( VBIX ) will acquire 100% of Quantum X Labs’ issued and outstanding share capital in exchange for the issuance of shares of the Company’s common stock and pre-funded warrants to purchase shares of the Company’s common stock on a pro-rate basis to Quantum X Labs’s shareholders. These securities issuable to Quantum X Labs’s shareholders upon the closing of the Acquisition will represent 65% of Viewbix's ( VBIX ) total post-closing issued and outstanding share capital, inclusive of shares issued concurrently via a PIPE financing of $3 million that the Company announced today.

QuantumX Labs is a cutting-edge quantum computing and AI company focusing on advancing technologies in quantum algorithmics and quantum physics. As the pioneering Israeli laboratory, it is committed to creating and retaining quantum innovations across diverse industries and sectors. The company currently maintains a diverse quantum ecosystem by owning subsidiaries that develop unique, patent-protected solutions.

The closing of the Acquisition and the issuance of the securities by Viewbix ( VBIX ) is expected to occur in December 2025, subject to final due diligence, the execution of definitive agreements, regulatory approvals, the approval of the Company’s stockholders in accordance with applicable rules or regulations of the Nasdaq Stock Market LLC and customary closing conditions.

About Viewbix Inc. ( VBIX )

Viewbix ( VBIX ), through certain of its subsidiaries Gix Media Ltd. and Cortex Media Group Ltd., operates in the field of digital advertising. The Group has two main activities search and digital content. The search develops a variety of technological software solutions, which perform automation, optimization and monetization of internet campaigns, for the purposes of acquiring and routing internet user traffic to its customers. The digital content is engaged in the creation and editing of content, in different languages, for different target audiences, for the purposes of generating revenues from leading advertising platforms, including Google, Facebook, Yahoo and Apple, by utilizing such content to obtain internet user traffic for its advertisers. Viewbix’s technological tools allow advertisers and website owners to earn more from their advertising campaigns and generate additional profits from their websites.

For more information about Viewbix ( VBIX ), visit https://view-bix.com/

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the signing of definitive agreements with Quantum X Labs, the timing and completion of the Acquisition, the receipt of regulatory approvals, the receipt of approval by the Company’s stockholders and the satisfaction of closing conditions related to the Acquisition. Because such statements deal with future events and are based on Viewbix’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Viewbix ( VBIX ) undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Viewbix ( VBIX ) is not responsible for the contents of third-party websites.

Investor Relations Contacts:

Michal Efraty

Investor Relations

[email protected]

Image: https://www.globenewswire.com/newsroom/ti?nf=OTU2OTMyMiM3MjQ1ODkxIzUwMDA2NDMwMg==

Image: https://ml.globenewswire.com/media/YmYwODJlOTItNGNjNi00N2RhLWIzNDUtNjc4MjZlZWViYmM4LTUwMDA2NDMwMi0yMDI1LTExLTA1LWVu/tiny/Viewbix-Inc-.png Image: Primary Logo

Source: Viewbix Inc. ( VBIX )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved